Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
|Articles|September 1, 2002
- Volume 0 0
Insulin-Producing Stem Cells Created
Advertisement
Stem cells may hold the key to actually curing diabetes. As reported in Endocrinology (August 2002), researchers from Massachusetts General Hospital in Boston took human pancreas islet stem cells and exposed them to the hormone glucagon-like peptide-1 (GLP-1). That caused the islet stem cells to begin producing insulin. The notion is that transplanting insulin-producing cells from a person?s own stem cells will prevent rejection by the immune system. The investigators emphasize, however, that much more research is needed.
Articles in this issue
about 24 years ago
Seperate Powders??about 24 years ago
Pure testosterone isocaproate powder...about 24 years ago
Delivery of progesterone...about 24 years ago
Try a Little Exerciseabout 24 years ago
Seasonal Affective Disorderabout 24 years ago
Most Asthmatics Are Not Using Anti-inflammatory Drugsabout 24 years ago
New Guidelines on Inhaler Packaging Are Issuedabout 24 years ago
Big Babies Have Reduced Diabetes Riskabout 24 years ago
Niacin Therapyabout 24 years ago
Whole-Grain HealthAdvertisement
Related to this article
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Pharmacists are well equipped to manage DOAC therapy by providing initial education, adherence support, and safety monitoring.
Pharmacists play a key role in guiding age- and risk-based vaccination decisions to protect against invasive and noninvasive disease.
Peer Reviewed
Gepotidacin and zoliflodacin show comparable efficacy to standard care for urogenital gonorrhea, offering promising alternatives given the recent rise in antimicrobial resistance.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
3
Adult Pneumococcal Immunizations: A Practical Guide for Pharmacists
4
Radioligand Therapy Doesn’t Need to Be Risk-Free—It Needs to Be Worth It
5